BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 29643230)

  • 1. The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy.
    Krall JA; Reinhardt F; Mercury OA; Pattabiraman DR; Brooks MW; Dougan M; Lambert AW; Bierie B; Ploegh HL; Dougan SK; Weinberg RA
    Sci Transl Med; 2018 Apr; 10(436):. PubMed ID: 29643230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer.
    Bonneau C; Eliès A; Kieffer Y; Bourachot B; Ladoire S; Pelon F; Hequet D; Guinebretière JM; Blanchet C; Vincent-Salomon A; Rouzier R; Mechta-Grigoriou F
    Breast Cancer Res; 2020 Jul; 22(1):76. PubMed ID: 32665033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells.
    Maenz C; Lenfert E; Pantel K; Schumacher U; Deppert W; Wegwitz F
    BMC Cancer; 2015 Mar; 15():178. PubMed ID: 25886487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local and distant tumor dormancy during early stage breast cancer are associated with the predominance of infiltrating T effector subsets.
    Aqbi HF; Coleman C; Zarei M; Manjili SH; Graham L; Koblinski J; Guo C; Xie Y; Guruli G; Bear HD; Idowu MO; Habibi M; Wang XY; Manjili MH
    Breast Cancer Res; 2020 Oct; 22(1):116. PubMed ID: 33115528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer.
    Lan Q; Peyvandi S; Duffey N; Huang YT; Barras D; Held W; Richard F; Delorenzi M; Sotiriou C; Desmedt C; Lorusso G; Rüegg C
    Oncogene; 2019 Apr; 38(15):2814-2829. PubMed ID: 30546090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy.
    Demicheli R; Abbattista A; Miceli R; Valagussa P; Bonadonna G
    Breast Cancer Res Treat; 1996; 41(2):177-85. PubMed ID: 8944336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic-Immune Checkpoint Therapy Eradicates Local and Distant Tumors by CD8
    Kleinovink JW; Fransen MF; Löwik CW; Ossendorp F
    Cancer Immunol Res; 2017 Oct; 5(10):832-838. PubMed ID: 28851692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer.
    Ghaffari A; Hoskin V; Turashvili G; Varma S; Mewburn J; Mullins G; Greer PA; Kiefer F; Day AG; Madarnas Y; SenGupta S; Elliott BE
    Breast Cancer Res; 2019 Jan; 21(1):12. PubMed ID: 30678714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting Mouse Models to Recapitulate Clinical Tumor Dormancy and Recurrence in Breast Cancer.
    Gu Y; Bui T; Muller WJ
    Endocrinology; 2022 Jun; 163(6):. PubMed ID: 35560214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo.
    Lavender N; Yang J; Chen SC; Sai J; Johnson CA; Owens P; Ayers GD; Richmond A
    BMC Cancer; 2017 Jan; 17(1):88. PubMed ID: 28143493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative insight into metastatic relapse of breast cancer.
    Hanin L; Pavlova L
    J Theor Biol; 2016 Apr; 394():172-181. PubMed ID: 26801873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients.
    Ogiya R; Niikura N; Kumaki N; Bianchini G; Kitano S; Iwamoto T; Hayashi N; Yokoyama K; Oshitanai R; Terao M; Morioka T; Tsuda B; Okamura T; Saito Y; Suzuki Y; Tokuda Y
    Cancer Sci; 2016 Dec; 107(12):1730-1735. PubMed ID: 27727484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer.
    van der Bij GJ; Oosterling SJ; Beelen RH; Meijer S; Coffey JC; van Egmond M
    Ann Surg; 2009 May; 249(5):727-34. PubMed ID: 19387333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cell dormancy: implications for the biology and treatment of breast cancer.
    Fehm T; Mueller V; Marches R; Klein G; Gueckel B; Neubauer H; Solomayer E; Becker S
    APMIS; 2008; 116(7-8):742-53. PubMed ID: 18834416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
    Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
    Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation of colorectal liver metastases induces an inflammatory response in distant hepatic metastases but not in local accelerated outgrowth.
    Nijkamp MW; Borren A; Govaert KM; Hoogwater FJ; Molenaar IQ; van Diest PJ; Kranenburg O; Borel Rinkes IH
    J Surg Oncol; 2010 Jun; 101(7):551-6. PubMed ID: 20461760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms governing metastatic dormancy in breast cancer.
    Dittmer J
    Semin Cancer Biol; 2017 Jun; 44():72-82. PubMed ID: 28344165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
    Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of immunity in mice cured of primary/metastatic growth of EMT6 or 4THM breast cancer by chemotherapy or immunotherapy.
    Gorczynski RM; Chen Z; Erin N; Khatri I; Podnos A
    PLoS One; 2014; 9(11):e113597. PubMed ID: 25409195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.